November 1, 2020 (Est.)
Amp Volatility Score
Catalyst Info & Data Links
TITLE: Altimmune AdCOVID (COVID-19 Intranasal Vaccine) Phase 1 begins
WHAT IS THE NEXT CATALYST EVENT?
Phase 1 begins
WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?
November 1, 2020 (Est)
08-12-2020 Company Slide deck (Slides 10-14)
MECHANISM OF ACTION
By utilizing the Company’s proprietary intranasal vaccine technology, it is expected that AdCOVID has the potential to activate multiple arms of the immune system as shown in a recent Phase 2 clinical study with NasoVAX, an influenza vaccine candidate based on the same platform technology. That study showed potent stimulation of mucosal and cellular immune responses in addition to a strong serum antibody response.
Updated by MV
#COVID #COVIDVACCINE #ALT #ALTIMMUNE
Prior Data (click to view full image)
Trial Design / Revenue (click to view full image)
See What The Community Is Saying - Click To See Full Post